MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by ameda33on Jan 28, 2021 3:17pm

81 Views

Post# 32412429

Discovery of Applications

Sponsored Post:

Are you aware of the many health benefits of medical green leaf? You’re in for a ride.

Along the way, green leaf appears to be revolutionizing the way medical issues are being treated globally. Researchers seem to be studying the chemicals in green leaf to discover new applications. Some of these chemicals already seem to be aiding in the treatment of epilepsy, neuropsychiatric disorders, cancer, chronic pain, and anxiety, for example.

These other companies’ products claim to deliver measured amounts of green leaf straight to the systemic bloodstream. Check disclaimer on profile and landing page.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading